Search Results - "Pinessi, Denise"
-
1
Alternative Vascularization Mechanisms in Tumor Resistance to Therapy
Published in Cancers (15-04-2021)“…Blood vessels in tumors are formed through a variety of different mechanisms, each generating vessels with peculiar structural, molecular, and functional…”
Get full text
Journal Article -
2
Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma
Published in Carcinogenesis (New York) (29-04-2019)“…Abstract Trabectedin is a marine-derived antineoplastic drug. Besides targeting the cancer cells, trabectedin has a peculiar activity on the tumor…”
Get full text
Journal Article -
3
Current understanding of the thrombospondin-1 interactome
Published in Matrix biology (01-07-2014)“…The multifaceted action of thrombospondin-1 (TSP-1) depends on its ability to physically interact with different ligands, including structural components of…”
Get full text
Journal Article -
4
Abstract 198: The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract The disorganized and inefficient nature of the tumor vasculature affects the delivery and activity of antineoplastic treatments. Certain…”
Get full text
Journal Article -
5
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2)
Published in Angiogenesis (London) (01-02-2019)“…Thrombospondin (TSP)-1 and TSP-2 share similar structures and functions, including a remarkable antiangiogenic activity. We have previously demonstrated that a…”
Get full text
Journal Article -
6
Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activity
Published in Matrix biology (01-09-2021)“…•The abnormal morphological and functional properties of the tumor vasculature are a major hindrance to the distribution and efficacy of antineoplastic…”
Get full text
Journal Article -
7
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors
Published in Scientific reports (22-03-2016)“…The FGFs/FGFRs system is a recognized actionable target for therapeutic approaches aimed at inhibiting tumor growth, angiogenesis, metastasis, and resistance…”
Get full text
Journal Article -
8
Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2
Published in Pigment cell and melanoma research (01-01-2015)“…Summary Differently from most transformed cells, cutaneous melanoma expresses the pleiotropic factor thrombospondin‐1 (TSP‐1). Herein, we show that TSP‐1 (RNA…”
Get full text
Journal Article -
9
Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts
Published in Connective tissue research (03-09-2015)“…Thrombospondin-1 (TSP-1), a major regulator of cell interaction with the environment, is often deregulated in cancers, including ovarian carcinoma. Both the…”
Get more information
Journal Article